Fludarabine in the treatment of chronic lymphocytic leukemia: a review

por Ricci, Francesca, Tedeschi, Alessandra, Morra, Enrica, Montillo, Marco
Publicado 2009

Therapy-Related Myeloid Neoplasms in Chronic Lymphocytic Leukemia and Waldenstrom’s Macroglobulinemia

por Ricci, Francesca, Tedeschi, Alessandra, Montillo, Marco, Morra, Enrica
Publicado 2011

Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)

por Montillo, Marco, Ricci, Francesca, Miqueleiz, Sara, Tedeschi, Alessandra, Morra, Enrica
Publicado 2008

The spectrum of use of rituximab in chronic lymphocytic leukemia

por Tedeschi, Alessandra, Vismara, Eleonora, Ricci, Francesca, Morra, Enrica, Montillo, Marco
Publicado 2010

Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia

por Frustaci, Anna Maria, Tedeschi, Alessandra, Picardi, Paola, Cairoli, Roberto, Montillo, Marco
Publicado 2015

Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities

por Frustaci, Anna Maria, Deodato, Marina, Zamprogna, Giulia, Cairoli, Roberto, Montillo, Marco, Tedeschi, Alessandra
Publicado 2023

Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper

por Cuneo, Antonio, Barosi, Giovanni, Danesi, Romano, Fagiuoli, Stefano, Ghia, Paolo, Marzano, Alfredo, Montillo, Marco, Poletti, Venerino, Viale, Pierluigi, Zinzani, Pier Luigi
Publicado 2018

Reply to “CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report” Analysis of six hematological centers in Lombardy: On behalf of CLL commission of Lombardy Hemato...

por Reda, Gianluigi, Noto, Alessandro, Cassin, Ramona, Zamprogna, Giulia, Borella, Chiara, Scarfò, Lydia, Farina, Lucia, Molteni, Alfredo, Ghia, Paolo, Tedeschi, Alessandra, Montillo, Marco
Publicado 2020

Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN study

por Leblond, Véronique, Aktan, Melih, Ferra Coll, Christelle M., Dartigeas, Caroline, Kisro, Jens, Montillo, Marco, Raposo, João, Merot, Jean-Louis, Robson, Susan, Gresko, Ekaterina, Bosch, Francesc, Stilgenbauer, Stephan, Foà, Robin
Publicado 2018

Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial

por Montillo, Marco, Illés, Árpád, Robak, Tadeusz, Pristupa, Alexander S., Wach, Malgorzata, Egyed, Miklós, Delgado, Julio, Jurczak, Wojciech, Morschhauser, Franck, Schuh, Anna, Eradat, Herbert, Shreay, Sanatan, Barrientos, Jacqueline C., Zelenetz, Andrew D.
Publicado 2019

IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic...

por Bulian, Pietro, Rossi, Davide, Forconi, Francesco, Del Poeta, Giovanni, Bertoni, Francesco, Zucca, Emanuele, Montillo, Marco, Pozzato, Gabriele, D'Arena, Giovanni, Efremov, Dimitar G, Marasca, Roberto, Lauria, Francesco, Gaidano, Gianluca, Gattei, Valter, Laurenti, Luca
Publicado 2012

S147: EFFICACY AND SAFETY RESULTS OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME

por Frustaci, Anna Maria, Montillo, Marco, Rossi, Davide, Zinzani, Pier Luigi, Motta, Marina, Gaidano, Gianluca, Quaresmini, Giulia, Scarfò, Lydia, Pietrasanta, Daniela, Coscia, Marta, Deodato, Marina, Zamprogna, Giulia, Cairoli, Roberto, Stüssi, Georg, Zucca, Emanuele, Pileri, Stefano, Zenz, Thorsten, Tedeschi, Alessandra
Publicado 2023

Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia

por Steurer, Michael, Montillo, Marco, Scarfò, Lydia, Mauro, Francesca R., Andel, Johannes, Wildner, Sophie, Trentin, Livio, Janssens, Ann, Burgstaller, Sonja, Frömming, Anna, Dümmler, Thomas, Riecke, Kai, Baumann, Matthias, Beyer, Diana, Vauléon, Stéphanie, Ghia, Paolo, Foà, Robin, Caligaris-Cappio, Federico, Gobbi, Marco
Publicado 2019

S201: FINAL 7-YEAR FOLLOW UP AND RETREATMENT SUBSTUDY ANALYSIS OF MURANO: VENETOCLAX-RITUXIMAB (VENR)-TREATED PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CL...

por Kater, Arnon, Harrup, Rosemary, Kipps, Thomas J, Eichhorst, Barbara, Owen, Carolyn J, Assouline, Sarit, Lamanna, Nicole, Robak, Tadeusz, de la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Mellink, Clemens, Chyla, Brenda, Thadani-Mulero, Maria, Lefebure, Marcus, Jiang, Yanwen, Millen, Rosemary, Boyer, Michelle, Seymour, John F
Publicado 2023

Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma

por Munir, Talha, Brown, Jennifer R., O'Brien, Susan, Barrientos, Jacqueline C., Barr, Paul M., Reddy, Nishitha M., Coutre, Steven, Tam, Constantine S., Mulligan, Stephen P., Jaeger, Ulrich, Kipps, Thomas J., Moreno, Carol, Montillo, Marco, Burger, Jan A., Byrd, John C., Hillmen, Peter, Dai, Sandra, Szoke, Anita, Dean, James P., Woyach, Jennifer A.
Publicado 2019

Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab

por Seymour, John F., Kipps, Thomas J., Eichhorst, Barbara F., D’Rozario, James, Owen, Carolyn J., Assouline, Sarit, Lamanna, Nicole, Robak, Tadeusz, de la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Mellink, Clemens, Chyla, Brenda, Panchal, Anesh, Lu, Tong, Wu, Jenny Q., Jiang, Yanwen, Lefebure, Marcus, Boyer, Michelle, Kater, Arnon P.
Publicado 2022

Idelalisib or Placebo in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory CLL - Interim Results of a Phase 3 Randomized, Double-blind Placebo-Contro...

por Zelenetz, Andrew D., Barrientos, Jacqueline C., Brown, Jennifer R., Coiffier, Bertrand, Delgado, Julio, Egyed, Miklós, Ghia, Paolo, Illés, Árpád, Jurczak, Wojciech, Marlton, Paula, Montillo, Marco, Morschhauser, Franck, Pristupa, Alexander S., Robak, Tadeusz, Sharman, Jeff P., Simpson, David, Smolej, Lukáš, Tausch, Eugen, Adewoye, Adeboye H., Dreiling, Lyndah K., Kim, Yeonhee, Stilgenbauer, Stephan, Hillmen, Peter
Publicado 2017

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group

por Rigolin, Gian Matteo, Cavazzini, Francesco, Piciocchi, Alfonso, Arena, Valentina, Visentin, Andrea, Reda, Gianluigi, Zamprogna, Giulia, Cibien, Francesca, Vitagliano, Orsola, Coscia, Marta, Farina, Lucia, Gaidano, Gianluca, Murru, Roberta, Varettoni, Marzia, Paolini, Rossella, Sportoletti, Paolo, Pietrasanta, Daniela, Molinari, Anna Lia, Quaglia, Francesca M., Laurenti, Luca, Marasca, Roberto, Marchetti, Monia, Mauro, Francesca R., Crea, Enrico, Vignetti, Marco, Gentile, Massimo, Montillo, Marco, Foà, Robin, Cuneo, Antonio
Publicado 2021

Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?

por Tedeschi, Alessandra, Frustaci, Anna Maria, Mauro, Francesca Romana, Chiarenza, Annalisa, Coscia, Marta, Ciolli, Stefania, Reda, Gianluigi, Laurenti, Luca, Varettoni, Marzia, Murru, Roberta, Baratè, Claudia, Sportoletti, Paolo, Greco, Antonino, Borella, Chiara, Rossi, Valentina, Deodato, Marina, Biagi, Annalisa, Zamprogna, Giulia, Pelle, Angelo Curto, Lapietra, Gianfranco, Vitale, Candida, Morelli, Francesca, Cassin, Ramona, Fresa, Alberto, Cavalloni, Chiara, Postorino, Massimiliano, Ielo, Claudia, Cairoli, Roberto, Di Raimondo, Francesco, Montillo, Marco, Del Poeta, Giovanni
Publicado 2021

Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia

por Kaufman, Matthew, Yan, Xiao-Jie, Li, Wentian, Ghia, Emanuela M., Langerak, Anton W., Rassenti, Laura Z., Belessi, Chrysoula, Kay, Neil E., Davi, Frederic, Byrd, John C., Pospisilova, Sarka, Brown, Jennifer R., Catherwood, Mark, Davis, Zadie, Oscier, David, Montillo, Marco, Trentin, Livio, Rosenquist, Richard, Ghia, Paolo, Barrientos, Jacqueline C., Kolitz, Jonathan E., Allen, Steven L., Rai, Kanti R., Stamatopoulos, Kostas, Kipps, Thomas J., Neuberg, Donna, Chiorazzi, Nicholas
Publicado 2022